Dr Rebecca Coll

UQ Fellow

Institute for Molecular Bioscience
r.coll@imb.uq.edu.au
+61 7 334 62076

Overview

Qualifications

  • Doctor of Philosophy, Trinity(Dub )

Publications

  • Kammoun, H. L., Allen, T. L., Henstridge, D. C., Barre, S., Coll, R. C., Lancaster, G. I., Cron, L., Reibe, S., Chan, J. Y., Bensellam, M., Laybutt, D. R., Butler, M. S., Robertson, A. A. B., O'Neill, L. A., Cooper, M. A. and Febbraio, M. A. (2018) Evidence against a role for NLRP3-driven islet inflammation in db/db mice. Molecular Metabolism, 10 66-73. doi:10.1016/j.molmet.2018.02.001

  • Boucher, Dave, Monteleone, Mercedes, Coll, Rebecca C., Chen, Kaiwen W., Ross, Connie M., Teo, Jessica L., Gomez, Guillermo A., Holley, Caroline L., Bierschenk, Damien, Stacey, Katryn J., Yap, Alpha S., Bezbradica, Jelena S. and Schroder, Kate (2018) Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. The Journal of Experimental Medicine, 215 3: 827-840. doi:10.1084/jem.20172222

  • O'Neill, Luke , Coll, Rebecca , Cooper, Matt , Robertson, Avril , Schroder, Kate , Macleod, Angus Murray and Miller, David John (2017). Sulfonylureas and related compounds and use of the same. WO2017140778.

View all Publications

Supervision

  • Doctor Philosophy

View all Supervision

Publications

Journal Article

Conference Publication

  • West, Erin E., Arbore, Giuseppina, Robertson, Avril A. B., Klos, Andreas, Woodruff, Trent M., O'Neill, Luke A., Coll, Rebecca C., Sher, Alan, Leonard, Warren J., Koehl, Joerg, Monk, Pete, Cooper, Matthew A., Afzali, Behdad, Lachmann, Helen J., Cope, Andrew P., Mayer-Barber, Katrin and Kemper, Claudia (2016). Autocrine NLPR3 inflammasome activity is critical to normal adaptive immunity via regulation of IFN-gamma in CD4(+) T cells. In: Annual Meeting of the American Association of Immunologists (AAI), Seattle, WA, United States, (). 13-17 May 2016.

  • Kammoun, H. L., Allen, T. L., Henstridge, D. C., Barre, S., Coll, R. C., Butler, M. S., Roberston, A. A. B., O'Neill, L. A., Murphy, A. J., Cooper, M. A. and Febbraio, M. A. (2016). Evidence against a role for NLRP3-driven inflammation in the db/db mouse model of type 2 diabetes. In: International Congress of Immunology (ICI), Melbourne, VIC, Australia, (444-444). 21-26 August 2016. doi:10.1002/eji.201670200

  • Basiorka, A., Mcgraw, K., Eksioglu, E., Chen, X., Johnson, J., Padron, E., Komrokji, R., Sokol, L., Coll, R., O'Neill, L., Cooper, M., Robertson, A., Wei, S. and List, A. (2015). Activation of Redox-Sensitive Inflammasomes Underlies the Biological Phenotype of Myelodysplastic Syndromes. In: 13th International Symposium on Myelodysplastic Syndromes (MDS), Washington DC, United States, (S14-S14). Apr 29-May 02, 2015. doi:10.1016/S0145-2126(15)30033-3

  • McGarry, T., Robertson, A. A., Orr, C., Coll, R. C., Cooper, M. A., O'Neill, L. A., Veale, D. J. and Fearon, U. (2015). The effect of novel compound MCC950 On the NLRP3 inflammasome in the RA joint. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology, Rome, Italy, (202). 10-13 July 2015. doi:10.1136/annrheumdis-2015-eular.3985

  • Arbore, Giuseppina, Fara, Antonella F., Coll, Rebecca, Robertson, Avril, Cooper, Matthew, O'Neill, Luke A. J., Lavender, Paul, Cope, Andrew, Lachmann, Helen J. and Kemper, Claudia (2014). Control of the human Th1 response via autocrine complement-regulated NLRP3 inflammasome activation within CD4(+) T cells. In: Abstracts of the XXV International Complement Workshop. 25th International Complement Workshop, Rio de Janeiro, Brazil, (281-282). 14-18 September 2014. doi:10.1016/j.molimm.2014.07.010

  • Dempsey, Colin, Coll, Rebecca, Robertson, Avril, Cooper, Matthew, O'Neill, Luke and Lynch, Marina (2014). Cytokine release inhibitor drug, CRID3, inhibits the NLRP3 inflammasome in glia. In: 12th International Congress of Neuroimmunology (ISNI), Mainz Germany, (147-147). 9-13 November 2014. doi:10.1016/j.jneuroim.2014.08.393

  • Coll, Rebecca C., Robertson, Avril A. B., Chae, Jae Jin, Higgins, Sarah C., Dungan, Lara S., Munoz-Planillo, Raul, Monks, Brian G., Croker, Daniel E., Sutton, Caroline E., Stutz, Andrea, Nunez, Gabriel, Latz, Eicke, Kastner, Daniel L., Mills, Kingston H. G., Masters, Seth L., Schroder, Kate, Cooper, Matt A. and O'Neill, Luke A. J. (2014). MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases. In: 2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Melbourne Australia, (35-35). Oct 26-29, 2014. doi:10.1016/j.cyto.2014.07.037

  • McGarry, Trudy, Connolly, Mary, Coll, Rebecca C., Robertson, Avril A. B., Cooper, Matthew A., O'Neill, Luke A., Veale, Douglas J. and Fearon, Ursula (2014). Novel Compound Cytokine Release Inhibitory Drug 3 (CRID3) Inhibits the NLRP3 Inflammasome in Rheumatoid Arthritis. In: Abstract Supplement: 2014 ACR/ARHP Annual Meeting. 78th Annual Meeting of the American College of Rheumatology/49th Annual Meeting of the Association of Rheumatology Health Professionals, Boston, MA United States, (S461-S461). 14-19 November 2014.

  • Greenhill, C. J., Jones, G. W., Nowell, M. A., Harvey, A. K., Moideen, A. N., Collins, F. L., Bloom, A. C., Coll, R., Rosas, M., Taylor, P. R., O'Neill, L. A., Humphreys, I. R., Williams, A. S. and Jones, S. A. (2013). Interleukin 10 control of the inflammasome restricts arthritic bone erosion. In: Cytokine. Annual Joint Conference of the International-Cytokine-Society and the International-Society-for-Interferon-and-Cytokine-Research, San Francisco Ca, (267-267). Sep 29-Oct 03, 2013. doi:10.1016/j.cyto.2013.06.105

Other Outputs

PhD and MPhil Supervision

Current Supervision